Early decisions matter
Treat infants individually, specifically and in a timely manner. Prevent negative effects and complications. This is what the new generation of intelligent prediction software for obstetrics and neonatology is enabling.
Digitize scientific and clinical experience — a paradigm shift in maternal, neonatal and perinatal care. Clinical care of mothers and their children is supported and optimized by algorithms and artificial intelligence, scientifically substantiated.
The breakthrough prediction tool of NeoPrediX will support decision makers in clinics to optimize care and therapy for each individual patient. In doing so, we will facilitate therapeutic decisions for the most vulnerable patients, the newborns. It‘s about the moment. The future begins now.
What we do
The new generation
of analysis software
NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize intelligent algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists, pediatricians, and neonatologists.
Would you like to learn more about our company and our innovations?
We enhance and personalize healthcare in early life.
We transform medical data into intelligent predictions to support clinical decisions.
Designing the future of medicine. With you.
We are a young, innovative company in the medical technology software field. The company is a spin-off from the University of Basel. A diverse, highly motivated team driven by desire for achievement and passion for children and their families provides an ideal work environment. A high degree of independence and self-organization together with short decision-making paths makes us agile and efficient. We are developing new, individual treatment solutions to enhance perinatal and neonatal care.
Your input is appreciated.
Our current job opportunities:
The team of experts
Experience for progress -
a highly qualified leadership team
Thorsten Waloschek MBA is a senior industry executive who is passionate about bringing new and innovative products to market that have a positive impact on patients, their families and clinicians.
Jörg Schmidt is a senior financial executive in Life Sciences and the MedTech industry who is passionate about leading financial business projects to bring innovative companies & their products to market successfully.